Teva Xtampza Settlement Brings Potential Three-Year Head Start
Suit In Delaware Court Settled With 2033 Date
Executive Summary
Teva is lining up another complex ANDA product after agreeing to settle litigation with Collegium Pharmaceutical over the Israeli firm’s proposed generic version of Xtampza ER (oxycodone) extended-release capsules.